Loading organizations...
§ Venture Capital · Auckland, New Zealand
Food and health sector impact investor providing growth stage financing for companies across health and wellness markets.
Key people at Covalent Ventures.
Covalent Ventures is a growth-stage venture capital firm and impact investor focused on the food and health sectors, with headquarters based in New Zealand and Switzerland. The organization provides financing to scaling companies operating across diverse wellness markets, including novel ingredients, biotechnology, medical devices, and digital healthcare systems. Through its investment syndication model on AngelList, the firm frequently allocates capital alongside prominent venture capital entities such as Bessemer Venture Partners, Craft Ventures, Sequoia Capital, and Khosla Ventures. The firm's active portfolio features health and wellness brands like DiaMedCare, financing their expansion into global consumer and medical markets. In August 2025, the firm expanded its operational capabilities through the strategic acquisition of Materials Characterization Services. Covalent Ventures was officially founded in 2021, though the specific names of its founding partners remain undisclosed in public filings.
Key people at Covalent Ventures.
Covalent Ventures has 1 tracked investment across 1 company. The latest tracked deal is $50.0M Series B in Certn in May 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2022 | Certn | $50.0M Series B | B Capital Group | Andreessen Horowitz, Boldstart Ventures, Chalfen Ventures, Coatue, Hanabi Capital, IA Seed Ventures, Inovia Capital, Insight Partners, Lobby Capital, Trace Cohen, Scribble Ventures, Semble Ventures, Tribe Capital, WestWave Capital, Ameet Patel, GUY Podjarny, Thomas Noonan, BMO Capital Partners, Gaingels, Moxxie Ventures, Telstra Ventures, Tribe |
Covalent Ventures is a venture capital firm specializing in the food and health sectors, focusing on scaling growth-stage companies into global brands with real-world impact. Their investment philosophy centers on responsible, impact-driven investing across a broad range of sectors including food systems, nutrition, biotech/pharma, medical devices, digital health, healthcare systems, novel ingredients, and consumer packaged goods. They leverage deep sector expertise and extensive global networks to provide portfolio companies with strategic advantages in major markets, primarily targeting New Zealand-based companies with revenue and helping them scale internationally[1][2][3].
Founded in 2020, Covalent Ventures is headquartered in Auckland, New Zealand, with a small but experienced team. The firm was established by partners with strong backgrounds in biotechnology, chemical engineering, healthcare market research, and nonprofit sectors. Key figures include Kelvin, with board experience in biotech and research consortia, and Chris, a former CEO and founding partner of a healthcare market research consultancy in Basel. Their combined expertise and commitment to health and food innovation shaped the firm's focus on impact investing and scaling companies globally[1][3].
Covalent Ventures rides the growing global trend of health and food innovation driven by increasing consumer demand for sustainable, nutritious, and technologically advanced solutions. The timing is favorable due to rising awareness of health impacts, regulatory shifts, and technological advancements in biotech and digital health. Their focus on scaling companies from New Zealand to global markets aligns with the increasing globalization of health and food tech ecosystems. By providing capital and strategic support, Covalent Ventures helps bridge local innovation with international growth opportunities, influencing the broader ecosystem by accelerating impactful startups in critical sectors[1][2][3].
Looking ahead, Covalent Ventures is poised to deepen its impact by continuing to scale innovative health and food companies globally, leveraging emerging trends such as personalized nutrition, biotech breakthroughs, and digital health integration. Their influence is likely to grow as they expand their portfolio and strengthen global partnerships, potentially increasing their role as a key enabler of sustainable and health-focused innovation. The firm’s commitment to responsible investing and sector expertise positions it well to capitalize on evolving market demands and regulatory environments, making it a significant player in the health and food venture capital space[1][2][3].